• Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

  • 2020/09/24
  • 再生時間： 47 分
  • ポッドキャスト

Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

科学
続きを読む 一部表示

Episode 20 - KINECT-HD with Dr. Dietrich Haubenbergerに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。